TY - JOUR
T1 - Inactivation of γ-aminobutyric acid aminotransferase by l-3-chloroalanine hydroxamate
AU - Silverman, Richard B.
AU - Olson, Gregory T.
N1 - Funding Information:
Financial support of this research by the National Institutes of Health (Grant NS15703) is gratefully acknowledged.
PY - 1995/1
Y1 - 1995/1
N2 - The mechanism of inactivation of γ-aminobutyric acid aminotransferase (GABA-AT) by l-3-chloroalanine hydroxamate (1) was investigated. Inactivation of [3H]PLP-reconstituted GABA-AT with 1 followed by denaturation gave no PMP or enamine adduct to the PLP; however, a new unknown metabolite was observed which was identical to the metabolite formed upon inactivation of GABA-AT by l-cycloserine. Time-dependent inactivation occurs, but the kinetics are second order; the rate of inactivation increases with time. After inactivation occurs the addition of fresh enzyme results in a faster rate of inactivation than prior to the initial inactivation. This indicates that the actual inactivator is generated from l-3-chloroalanine hydroxamate, and is not l-3-chloroalanine hydroxamate itself. Added gabaculine-inactivated enzyme to fresh enzyme does not increase the rate of inactivation, suggesting that the conversion of l-3-chloroalanine hydroxamate to the active form is not catalyzed by peripheral amino acid residues. l-3-Chloroalanine hydroxamate was shown to undergo buffer-catalyzed cyclization to l-cycloserine, which is the actual inactivator of GABA-AT.
AB - The mechanism of inactivation of γ-aminobutyric acid aminotransferase (GABA-AT) by l-3-chloroalanine hydroxamate (1) was investigated. Inactivation of [3H]PLP-reconstituted GABA-AT with 1 followed by denaturation gave no PMP or enamine adduct to the PLP; however, a new unknown metabolite was observed which was identical to the metabolite formed upon inactivation of GABA-AT by l-cycloserine. Time-dependent inactivation occurs, but the kinetics are second order; the rate of inactivation increases with time. After inactivation occurs the addition of fresh enzyme results in a faster rate of inactivation than prior to the initial inactivation. This indicates that the actual inactivator is generated from l-3-chloroalanine hydroxamate, and is not l-3-chloroalanine hydroxamate itself. Added gabaculine-inactivated enzyme to fresh enzyme does not increase the rate of inactivation, suggesting that the conversion of l-3-chloroalanine hydroxamate to the active form is not catalyzed by peripheral amino acid residues. l-3-Chloroalanine hydroxamate was shown to undergo buffer-catalyzed cyclization to l-cycloserine, which is the actual inactivator of GABA-AT.
UR - http://www.scopus.com/inward/record.url?scp=0028901875&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028901875&partnerID=8YFLogxK
U2 - 10.1016/0968-0896(94)00145-S
DO - 10.1016/0968-0896(94)00145-S
M3 - Article
C2 - 8612042
AN - SCOPUS:0028901875
SN - 0968-0896
VL - 3
SP - 11
EP - 18
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
IS - 1
ER -